Gold prices steady as traders assess Fed rate outlook after soft US data
In a remarkable display of market confidence, Know Labs Inc. shares have surged to an all-time high, reaching a price level of $5.24. According to InvestingPro data, the stock generally trades with high price volatility, making this milestone particularly noteworthy. This milestone underscores a period of significant growth for the company, which has seen its stock value skyrocket by an impressive 386.2% over the past year. While investors have rallied behind Know Labs, buoyed by the company’s innovative technology and potential for disruption in its industry, InvestingPro analysis reveals the company is currently not profitable and faces challenges with cash burn. Get access to 10+ additional key insights about Know Labs with an InvestingPro subscription. The ascent to this record price point reflects a broader trend of enthusiasm for companies that demonstrate strong potential for future gains, and Know Labs has certainly captured the market’s attention with its trajectory thus far. Despite trading near its 52-week high, the stock has experienced significant price fluctuations over the past six months.
In other recent news, Know Labs Inc. reported a net loss of $4.67 million for the first quarter of fiscal year 2025, an increase from the $3.45 million loss in the same period last year. Despite the widened loss, the company successfully reduced its cash burn rate by 44% to $1.89 million. Know Labs is actively expanding its technological reach, having launched a new licensing program for its Radio Frequency Dielectric Spectroscopy (RFDS) sensor platform. The company aims to monetize its technology through strategic partnerships and licensing agreements, which could be crucial given its limited cash reserves of $1.03 million, down from $3.11 million in September. Additionally, Know Labs is pursuing FDA approval for its Know You product, which is part of its broader strategy to enhance revenue streams. The company is also addressing challenges from short sellers and a trading suspension by the NYSE. Future funding efforts include plans to raise additional capital through equity issuance, preferred stock, and convertible debentures.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.